Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.29 CNY -4.61% Market Closed
Market Cap: 8.1B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Jiangsu Kanion Pharmaceutical Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jiangsu Kanion Pharmaceutical Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Other Long-Term Assets
ÂĄ60m
CAGR 3-Years
15%
CAGR 5-Years
-13%
CAGR 10-Years
-2%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Long-Term Assets
ÂĄ215.7m
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
8%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Long-Term Assets
ÂĄ702.3m
CAGR 3-Years
24%
CAGR 5-Years
25%
CAGR 10-Years
33%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Long-Term Assets
ÂĄ928.6m
CAGR 3-Years
16%
CAGR 5-Years
12%
CAGR 10-Years
20%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Long-Term Assets
ÂĄ84.9m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiangsu Kanion Pharmaceutical Co Ltd
Glance View

Market Cap
8.3B CNY
Industry
Pharmaceuticals

Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacturing and sale of Chinese patent medicine preparations and health products. The company is headquartered in Lianyungang, Jiangsu and currently employs 5,045 full-time employees. The company went IPO on 2002-09-18. The firm provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The firm's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The firm distributes its products mainly within domestic markets.

Intrinsic Value
23.69 CNY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Jiangsu Kanion Pharmaceutical Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
60m CNY

Based on the financial report for Jun 30, 2024, Jiangsu Kanion Pharmaceutical Co Ltd's Other Long-Term Assets amounts to 60m CNY.

What is Jiangsu Kanion Pharmaceutical Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
-2%

Over the last year, the Other Long-Term Assets growth was 37%. The average annual Other Long-Term Assets growth rates for Jiangsu Kanion Pharmaceutical Co Ltd have been 15% over the past three years , -13% over the past five years , and -2% over the past ten years .

Back to Top